Fidelity Select Pharmaceuticals Portfolio (FPHAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
23.47
+0.05 (0.21%)
Aug 8, 2025, 4:00 PM EDT
0.21%
Fund Assets1.04B
Expense Ratio0.67%
Min. Investment$0.00
Turnover51.00%
Dividend (ttm)1.12
Dividend Yield4.76%
Dividend Growth1.46%
Payout FrequencySemi-Annual
Ex-Dividend DateApr 11, 2025
Previous Close23.42
YTD Return-7.45%
1-Year Return-16.51%
5-Year Return31.85%
52-Week Low22.01
52-Week High31.58
Beta (5Y)0.54
Holdings57
Inception DateJun 18, 2001

About FPHAX

The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Fund Family Fidelity
Category Health
Stock Exchange NASDAQ
Ticker Symbol FPHAX
Index S&P 500 TR

Performance

FPHAX had a total return of -16.51% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.91%.

Top 10 Holdings

79.76% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY25.34%
Novo Nordisk A/SNVO14.12%
AstraZeneca PLCAZN9.59%
UCB SAUCB5.18%
Royalty Pharma plcRPRX5.09%
Gilead Sciences, Inc.GILD5.01%
GSK plcGSK4.77%
Merck & Co., Inc.MRK4.31%
Elanco Animal Health IncorporatedELAN3.30%
Legend Biotech CorporationLEGN3.05%

Dividend History

Ex-DividendAmountPay Date
Apr 11, 2025$0.861Apr 14, 2025
Dec 26, 2024$0.254Dec 27, 2024
Apr 12, 2024$0.227Apr 15, 2024
Dec 21, 2023$0.872Dec 22, 2023
Apr 14, 2023$1.035Apr 17, 2023
Dec 16, 2022$0.925Dec 19, 2022